Effect of theobromine-containing toothpaste on dentin tubule occlusion in situ

Clinical Oral Investigations

Volumn 19, Issue 1, 2015, Pages 109-116

  Amaechi, Bennett T ^a   Mathews, Sapna M ^a   Mensinkai, Poornima K ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Dentifrice; Dentin hypersensitivity; Novamin ; Theobromine; Theodent; Tubule occlusion

Indexed keywords

DESENSITIZING AGENT; GLASS; HYDRATED SILICA GEL-BASED TOOTHPASTE; NOVAMIN; OXALIC ACID DERIVATIVE; SENSODYNE DENTIN DESENSITIZER; SILICIC ACID; THEOBROMINE; TOOTHPASTE;

ADULT; COMPARATIVE STUDY; CONTROLLED STUDY; DENTIN SENSITIVITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; SCANNING ELECTRON MICROSCOPY; TIME FACTOR; TREATMENT OUTCOME;

ADULT; DENTIFRICES; DENTIN DESENSITIZING AGENTS; DENTIN SENSITIVITY; DOUBLE-BLIND METHOD; FEMALE; GLASS; HUMANS; MALE; MICROSCOPY, ELECTRON, SCANNING; OXALATES; SILICIC ACID; THEOBROMINE; TIME FACTORS; TOOTHPASTES; TREATMENT OUTCOME;

EID: 84896562122     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-014-1226-1     Document Type: Article

References (39)

1. Canadian Advisory Board on Dentin Hypersensitivity (2003) Consensus-based recommendations for the diagnosis and management of dentin hypersensitivity. J Can Dent Assoc 69:221–226
2. Addy M, Hunter ML (2003) Can tooth brushing damage your health? Effects on oral and dental tissues. Int Dent J 53(Suppl 3):177–186
3. Splieth CH, Tachou A (2013) Epidemiology of dentin hypersensitivity. Clin Oral Invest 17(Suppl 1):S3–S8
4. Cunha-Cruz J, Wataha JC, Heaton LJ, Rothen M, Sobieraj M, Scott J, Berg J, Northwest Practice-based Research Collaborative in Evidence-based dentistry (2013) The prevalence of dentin hypersensitivity in general dental practices in the northwest United States. J Am Dent Assoc 144:288–296
5. Schmidlin PR, Sahrmann P (2013) Current management of dentin hypersensitivity. Clin Oral Invest 17(Suppl 1):S55–S59. doi:10.1007/s00784-012-0912-0
6. Orchardson R, Gillam DG (2000) The efficacy of potassium salts as agents for treating dentin hypersensitivity. J Orofac Pain 14:9–19
7. Poulsen S, Errboe M, Hovgaard O, Worthington HW (2001) Potassium nitrate toothpaste for dentine hypersensitivity. Cochrane Database Syst Rev 2, CD001476
8. Orchardson R, Gillam DG (2006) Managing dentin hypersensitivity. J Am Dent Assoc 137:990–998
9. Dragolich WE, Pashley DH, Brennan WA, O’Neal RB, Horner JA, Van dyke TE (1993) An in vitro study of dentinal tubule occlusion by ferric oxalate. J Periodontol 48:1045–1051
10. Kakaboura A, Rahiotis C, Thomaidis S, Doukoudakis S (2005) Clinical effectiveness of two agents on the treatment of tooth cervical hypersensitivity. Am J Dent 18:291–295
11. Schupbach P, Lutz F, Finger WJ (1997) Closing of dentinal tubules by Gluma desensitizer. Eur J Oral Sci 105:414–421
12. Duran I, Sengun A, Yildirim T, Ozturk B (2005) In vitro dentine permeability evaluation of HEMA-based (desensitizing) products using split-chamber model following in vivo application in the dog. J Oral Rehabil 32:34–38
13. Schmidlin PR, Zehnder M, Gohring TN, Waltimo TM (2004) Glutaraldehyde in bonding systems disinfects dentin in vitro. J Adhes Dent 6:61–64
14. Stawarczyk B, Hartmann R, Hartmann L, Roos M, Ozcan M, Sailer I et al (2011) The effect of dentin desensitizer on shear bond strength of conventional and self-adhesive resin luting cements after aging. Oper Dent 36:492–501
15. Arenholt-Bindslev D, Horsted-Bindslev P, Philipsen HP (1987) Toxic effects of two dental materials on human buccal epithelium in vitro and monkey buccal mucosa in vivo. Scand J Dent Res 95:467–474
16. Schweikl H, Schmalz G (1997) Glutaraldehyde-containing dentin bonding agents are mutagens in mammalian cells in vitro. J Biomed Mater Res 36:284–288
17. Cummins D (2010) Recent advances in dentin hypersensitivity: clinically proven treatments for instant and lasting sensitivity relief. Am J Dent 23(Spec No A):3A–13A
18. Gendreau L, Barlow AP, Mason SC (2011) Overview of the clinical evidence for the use of NovaMin in providing relief from the pain of dentin hypersensitivity. J Clin Dent 22:90–95
19. Hughes N, Mason S, Jeffery P, Welton H, Tobin M, O’Shea C et al (2010) A comparative clinical study investigating the efficacy of a test dentifrice containing 8 % strontium acetate and 1040 ppm sodium fluoride versus a marketed control dentifrice containing 8 % arginine, calcium carbonate, and 1450 ppm sodium monofluorophosphate in reducing dentinal hypersensitivity. J Clin Dent 21:49–55
20. Ritter AV, de La Dias W, Miguez P, Caplan DJ, Swift EJJ (2006) Treating cervical dentin hypersensitivity with fluoride varnish: a randomized clinical study. J Am Dent Assoc 137:1013–1020
21. Gaffar A (1999) Treating hypersensitivity with fluoride varnish. Compend Contin Educ Dent 20(1 Suppl):27–33
22. Ipci SD, Cakar G, Kuru B, Yilmaz S (2009) Clinical evaluation of lasers and sodium fluoride gel in the treatment of dentine hypersensitivity. Photomed Laser Surg 27:85–91
23. Aparna S, Setty S, Thakur S (2010) Comparative efficacy of two treatment modalities for dentinal hypersensitivity: a clinical trial. Indian J Dent Res 21:544–548
24. Swift EJJ, May KNJ, Mitchell S (2001) Clinical evaluation of Prime & Bond 2.1 for treating cervical dentin hypersensitivity. Am J Dent 14:13–16
25. Schneider F, Hellwig E, Attin T (2008) Influences of acid action and brushing abrasion on dentin protection by adhesive systems. Dtsch Zahnärztl Zeitschr 57:302–306
26. Amaechi BT, Porteous N, Ramalingam K, Mensinkai PK, Ccahuana-Vasquez RA, Sadeghpour A et al (2013) Remineralization of artificial enamel lesions by theobromine. Caries Res 47:399–405
27. Nakamoto T, Simmons WB Jr, Falster AU (1999) Products of apatite-forming-systems. US Patent application number: US 5,919,426: http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/5919426
28. Nakamoto T, Simmons WB Jr, Falster AU (2001) Apatite-forming-systems: methods and products. US Patent application number: US 6,183,711 B1; http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/6183711
29. Najibfard K, Ramalingam K, Chedjieu I, Amaechi BT (2011) Remineralization of early caries by nano-hydroxyapatite dentifrice. J Clin Dent 22:139–143
30. Amaechi BT, Ramalingam K, Mensinksai PK, Narjibfard K, Mackey AC, Karlinsey RL (2010) Remineralization of eroded enamel by a NaF rinse containing a novel calcium phosphate agent in an in situ model: a pilot study. Clin Cosm Invest Dent 2:93–100
31. Claydon NC, Addy M, MacDonald EL, West NX, Maggio B, Barlow A, Parkinson C, Butler A (2009) Development of an in situ methodology for the clinical evaluation of dentine hypersensitivity occlusion ingredients. J Clin Dent 20:158–166
32. Strain P, Young WT (2004) Ethylene-oxide sterilisation aids speed to market. Med Device Technol 15:18–19
33. Mendes GC, Brandão TR, Silva CL (2007) Ethylene oxide sterilization of medical devices: a review. Am J Infect Control 35:574–581
34. Sreebny LM, Xerostomia VA (1987) A neglected symptom. Arch Intern Med 147:1333–1337
35. Cohen J (1960) A coefficient of agreement of nominal scales. Psychol Bull 20:37–46
36. Du Min Q, Bian Z, Jiang H, Greenspan DC, Burwell AK, Zhong J et al (2008) Clinical evaluation of a dentifrice containing calcium sodium phosphosilicate (novamin) for the treatment of dentin hypersensitivity. Am J Dent 21:210–214
37. Kielbassa AM, Attin T, Hellwig E, Schade-Brittinger C (1997) In vivo study on the effectiveness of a lacquer containing CaF2/NaF in treating dentine hypersensitivity. Clin Oral Invest 1:95–99
38. Catharina Z, Odile P, Martus P, Andrej MK (2006) Randomized clinical study on the efficacy of a new lacquer for dentine hypersensitivity. Schweiz Monatsschr Zahnmed 116:1232–1237
39. Burwell AK, Litkowski LJ, Greenspan DC (2009) Calcium sodium phosphosilicate (NovaMin®): remineralization potential. Adv Dent Res 21:35–39